[
    [
        {
            "time": "",
            "original_text": "民生医药|点评】天坛生物：业绩符合预期, 采浆量增长稳定，业绩确定性高",
            "features": {
                "keywords": [
                    "天坛生物",
                    "业绩",
                    "采浆量",
                    "增长稳定",
                    "业绩确定性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "民生医药|点评】天坛生物：业绩符合预期, 采浆量增长稳定，业绩确定性高",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "天坛生物（600161.SH）：全年业绩预增21%，未来能否保持稳健之势？",
            "features": {
                "keywords": [
                    "天坛生物",
                    "业绩预增",
                    "21%",
                    "未来",
                    "稳健"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "天坛生物（600161.SH）：全年业绩预增21%，未来能否保持稳健之势？",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "天坛生物：2019年年度业绩报告预告",
            "features": {
                "keywords": [
                    "天坛生物",
                    "2019年",
                    "年度业绩",
                    "报告预告"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "天坛生物：2019年年度业绩报告预告",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        }
    ]
]